JP Stock MarketDetailed Quotes

4892 Cyfuse Biomedical KK

Watchlist
  • 564
  • +2+0.36%
20min DelayTrading Nov 8 09:46 JST
4.59BMarket Cap-7478P/E (Static)

Cyfuse Biomedical KK Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Operating cash flow (Indirect Method)
Cash from operating activities
-69.18%-678.35M
-575.09%-400.96M
124.17%84.4M
-349.25M
Net profit before non-cash adjustment
-24.20%-586.19M
-425.68%-471.95M
144.25%144.91M
---327.49M
Total adjustment of non-cash items
-178.76%-86.79M
320.55%110.19M
-2,156.68%-49.96M
---2.21M
-Depreciation and amortization
-29.77%38.12M
193.50%54.29M
-43.77%18.5M
--32.89M
-Disposal profit
--0
--0
--0
--0
-Net exchange gains and losses
--0
-99.65%4K
281.22%1.16M
---639K
-Other non-cash items
-323.44%-124.91M
180.30%55.9M
-101.97%-69.62M
---34.47M
Changes in working capital
86.28%-5.38M
-271.26%-39.2M
45.97%-10.56M
---19.54M
-Change in receivables
70.78%-3.54M
44.78%-12.1M
-149.57%-21.91M
---8.78M
-Change in inventory
-126.42%-5.65M
155.46%21.37M
-284.71%-38.53M
--20.86M
-Change in prepaid assets
-105.97%-876K
279.30%14.67M
28.84%-8.18M
---11.5M
-Change in payables
137.58%8.37M
-146.75%-22.27M
169.06%47.63M
---68.97M
-Change in accrued expense
-130.36%-5.9M
1,351.01%19.43M
458.98%1.34M
---373K
-Changes in other current assets
103.66%2.21M
-764.03%-60.3M
-81.55%9.08M
--49.22M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
-30.62%-9.74M
-87.73%-7.45M
31.04%-3.97M
-5.76M
Interest received (cash flow from operating activities)
-7.14%39K
-84.33%42K
325.40%268K
63K
Tax refund paid
-21.50%-2.44M
0.00%-2.01M
0.00%-2.01M
-2.01M
Other operating cash inflow (outflow)
1,790.78%128.2M
-91.82%6.78M
31.62%82.85M
62.95M
Operating cash flow
-39.32%-562.3M
-349.85%-403.6M
154.94%161.54M
---294M
Investing cash flow
Net PPE purchase and sale
91.47%-19.47M
---228.28M
--0
---264K
Net investment product transactions
--0
---200M
--0
----
Net changes in other investments
----
95.26%-2.4M
---50.58M
----
Investing cash flow
95.48%-19.47M
-751.42%-430.67M
-19,060.23%-50.58M
---264K
Financing cash flow
Net issuance payments of debt
-101.38%-4.64M
651.43%336.94M
-89.95%44.84M
--446.35M
Net common stock issuance
-99.02%22.88M
1,020.70%2.33B
107.75%207.75M
--100M
Increase or decrease of lease financing
--0
50.26%-8M
-6.30%-16.08M
---15.13M
Net other fund-raising expenses
----
118.49%1.35M
82.74%-7.3M
---42.32M
Financing cash flow
-99.31%18.24M
1,059.89%2.66B
-53.12%229.21M
--488.91M
Net cash flow
Beginning cash position
113.09%3.44B
26.72%1.61B
18.05%1.27B
--1.08B
Current changes in cash
-130.89%-563.53M
436.30%1.82B
74.76%340.16M
--194.64M
Cash adjustments other than cash changes
----
-200.00%-1K
--1K
----
End cash Position
-16.39%2.87B
113.09%3.44B
26.72%1.61B
--1.27B
Free cash flow
7.93%-581.77M
-491.16%-631.87M
154.90%161.54M
---294.27M
Currency Unit
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Operating cash flow (Indirect Method)
Cash from operating activities -69.18%-678.35M-575.09%-400.96M124.17%84.4M-349.25M
Net profit before non-cash adjustment -24.20%-586.19M-425.68%-471.95M144.25%144.91M---327.49M
Total adjustment of non-cash items -178.76%-86.79M320.55%110.19M-2,156.68%-49.96M---2.21M
-Depreciation and amortization -29.77%38.12M193.50%54.29M-43.77%18.5M--32.89M
-Disposal profit --0--0--0--0
-Net exchange gains and losses --0-99.65%4K281.22%1.16M---639K
-Other non-cash items -323.44%-124.91M180.30%55.9M-101.97%-69.62M---34.47M
Changes in working capital 86.28%-5.38M-271.26%-39.2M45.97%-10.56M---19.54M
-Change in receivables 70.78%-3.54M44.78%-12.1M-149.57%-21.91M---8.78M
-Change in inventory -126.42%-5.65M155.46%21.37M-284.71%-38.53M--20.86M
-Change in prepaid assets -105.97%-876K279.30%14.67M28.84%-8.18M---11.5M
-Change in payables 137.58%8.37M-146.75%-22.27M169.06%47.63M---68.97M
-Change in accrued expense -130.36%-5.9M1,351.01%19.43M458.98%1.34M---373K
-Changes in other current assets 103.66%2.21M-764.03%-60.3M-81.55%9.08M--49.22M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities) -30.62%-9.74M-87.73%-7.45M31.04%-3.97M-5.76M
Interest received (cash flow from operating activities) -7.14%39K-84.33%42K325.40%268K63K
Tax refund paid -21.50%-2.44M0.00%-2.01M0.00%-2.01M-2.01M
Other operating cash inflow (outflow) 1,790.78%128.2M-91.82%6.78M31.62%82.85M62.95M
Operating cash flow -39.32%-562.3M-349.85%-403.6M154.94%161.54M---294M
Investing cash flow
Net PPE purchase and sale 91.47%-19.47M---228.28M--0---264K
Net investment product transactions --0---200M--0----
Net changes in other investments ----95.26%-2.4M---50.58M----
Investing cash flow 95.48%-19.47M-751.42%-430.67M-19,060.23%-50.58M---264K
Financing cash flow
Net issuance payments of debt -101.38%-4.64M651.43%336.94M-89.95%44.84M--446.35M
Net common stock issuance -99.02%22.88M1,020.70%2.33B107.75%207.75M--100M
Increase or decrease of lease financing --050.26%-8M-6.30%-16.08M---15.13M
Net other fund-raising expenses ----118.49%1.35M82.74%-7.3M---42.32M
Financing cash flow -99.31%18.24M1,059.89%2.66B-53.12%229.21M--488.91M
Net cash flow
Beginning cash position 113.09%3.44B26.72%1.61B18.05%1.27B--1.08B
Current changes in cash -130.89%-563.53M436.30%1.82B74.76%340.16M--194.64M
Cash adjustments other than cash changes -----200.00%-1K--1K----
End cash Position -16.39%2.87B113.09%3.44B26.72%1.61B--1.27B
Free cash flow 7.93%-581.77M-491.16%-631.87M154.90%161.54M---294.27M
Currency Unit JPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data